SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 25, 2026

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $696K total
Actionable Insight • Neutral

Insider sales at this scale are routine and carry no signal for Teva's stock. The EVP's sale is likely liquidity-driven (vesting or tax planning). Monitor for any 10b5-1 plan disclosures or upcoming earnings/catalyst events that could provide context, but no action warranted from this filing alone.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$37.92
T+0 close · Aug 25, 2026 · via day close
Latest settled
+6.07%
T+20 · $40.22 · next T+60 in 2d
Vs SPY
+5.67%
α at T+20
Latest observation
+23.00%
T+55 · FF3 residual α
  1. T+0 · Aug 26 $37.92entry
  2. T+1 · 3mo ago −0.79%α −1.45% · $37.62
  3. T+5 · 3mo ago −1.13%α −1.01% · $37.49
  4. T+20 · 8w ago +6.07%α +5.67% · $40.22
  5. T+57 · todayOpen
  6. T+60 · in 2d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two Teva insiders, a director and an EVP, sold a combined $696K in open-market sales over a one-week window. The EVP's $680K sale is the dominant trade; the director's $15K sale is de minimis. At a $43B market cap, the total represents ~0.0016% of market cap, well below the 0.1% materiality floor, making this cluster economically trivial and non-informative.

Key Financial Metrics

Direction
selling
Total Value
$696.0K
Insiders
2

Key Facts

  • EVP Evan Lippman sold 18,600 shares at $36.57 for $680K on 2026-08-17
  • Director Ronit Satchi-Fainaro sold 415 shares at $37.25 for $15K on 2026-08-21
  • Total cluster value of $696K represents ~0.0016% of Teva's $43B market cap
  • No insider buying in the cluster, net direction is selling

Financial Impact

$696K total insider sales, negligible relative to $43B market cap

insider holdings

Risk Factors

  • No material risk identified from this cluster, dollar amounts are trivial
  • If future insider sales accelerate above 0.1% of market cap, that would warrant attention

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TEVA-1787728399162

Track record

61 reports on TEVA

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $44.50 +3.10% settles Feb 12
  2. Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $44.50 0.00% settles Feb 11
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $44.50 0.00% settles Feb 11
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $44.50 +1.95% settles Feb 10
  5. Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $44.50 +2.91% settles Feb 9
  6. Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $44.50 +4.95% settles Feb 8
  7. Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $44.50 +4.95% settles Feb 8
  8. Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $44.50 +3.56% settles Feb 5
  9. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $44.50 +3.56% settles Feb 5
  10. Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $44.50 +4.44% settles Feb 4
Showing 10 of 61

US Market Status

Market Closed · Opens Wed (12h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 26, 2026